GeneTex
United States (US)

FGF9 recombinant protein

Cat No. GTX65088

Application ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Application Note

The ED50 as determined by the dose-dependent stimulation of thymidine uptake by BaF3 cells expressing FGF receptors is <0.5 ng/ml, corresponding to a specific activity of >2x10^6 units/mg.

Calculated MW

23.4 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Buffer

10 mM Tris, pH 7.8 + Ammmonium S

Storage

Reconstitute in 10 mM Tris (pH 8.0) to a concentration of 0.1-1.0 mg/ml. This solution can be diluted into other aqueous buffers and store at 4ºC for 1 week or stored at -20ºC for future use.

Antigen Species

Human

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥95%) and by HPLC (≥95%).

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Fibroblast Growth Factor-9, GAF (Gliaactivating factor), GAF (Glia-activating factor), HBGF-9, FGF9, HBGF9, Fibroblast Growth Factor9, HBGF 9, Fibroblast Growth Factor 9, GAF (Glia activating factor)

Background

FGF-9 (also known as Glial Activating Factor) is a heparin binding growth factor that stimulates the proliferation and activation of glial cells and other cells that express FGF receptors. The human FGF-9 is a 23.4 kDa protein containing 207 amino acid residues.

Research Area